The growth of this market is mainly driven by the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early... Continue Reading →

These needles are used for injecting the drug into the subcutaneous layer; this enables the quick absorption of active compounds into the bloodstream, which is a key factor contributing to the market growth of this segment. Key factors such growing geriatric population, increasing number of hospitals in emerging markets, and high prevalence of chronic diseases... Continue Reading →